GLP-1 Success A better GLP-1 journey starts here Mike -135 LBS *Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise
The increasing green color represents more similarity between molecules
The FDA approval is currently for adults with: A body mass index (BMI) of 30 or greater (obesity), or A BMI of 27 or greater (overweight) with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol The pill is not currently approved for type 1 diabetes (T1D) management, and the OASIS 4 trial excluded people with type 2 diabetes though that research is ongoing
Begin your weight loss journey today and see firsthand that semaglutide is a revolutionary way to shed pounds
Additionally, incorrect data were excluded, such as cases where the GLP-1 RA initiation date was later than the onset date of pancreatitis
Nausea management : If you're experiencing semaglutide-related nausea, taking acetaminophen may be challenging